WallStSmart
ATNM

Actinium Pharmaceuticals Inc

NYSE MKT: ATNM · HEALTHCARE · BIOTECHNOLOGY

$1.12
-4.70% today

Updated 2026-04-30

Market cap
$40.16M
P/E ratio
P/S ratio
446.22x
EPS (TTM)
$-1.09
Dividend yield
52W range
$1 – $2
Volume
0.2M

Actinium Pharmaceuticals Inc (ATNM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-0.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+9.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+5.3%
2025-11-24
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-13$-0.19-5.8%$1.13$1.11-1.8%
2025-11-24$-0.16+49.6%$1.33$1.40+5.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.18$-0.19-5.8%
2025-09-30$-0.32$-0.16+49.6%$90000.00
2025-06-30$-0.35$-0.22+36.8%
2025-03-31$-0.28$-0.51-83.8%
2024-12-31$-0.39$-0.21+46.2%$810000.00+900.0%
2024-09-30$-0.37$-0.37-0.9%
2024-06-30$-0.40$-0.38+5.0%
2024-03-31$-0.52$-0.31+40.4%
2023-12-31$-0.54$-0.34+37.0%$81000.00
2023-09-30$-0.53$-0.49+7.5%
2023-06-30$-0.48$-0.58-20.8%
2023-03-31$-0.42$-0.43-2.4%

Frequently asked questions

Has Actinium Pharmaceuticals Inc beaten earnings estimates?
Actinium Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -0.8% over the last 4 quarters.
How does ATNM stock react to earnings?
ATNM stock has moved an average of +1.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.